Quantcast
Home / Practice Areas / Business and Civil Practice / Supreme Court nixes human gene patents

Supreme Court nixes human gene patents

Court OKs synthetic DNA patents; both sides claim victory

WASHINGTON – In a decision that seemed designed to carve out a middle ground in the legal battle over whether companies can hold exclusive rights in the use of biological material, the U.S. Supreme Court ruled today that isolated human genes are not patentable, but synthetically created genetic material may be patented.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top